Glycemic trends, app engagement and achievement of gestational diabetes guideline targets using a diabetes app and Bluetooth® connected blood glucose meters

Mike Grady , Hilary Cameron , Elizabeth Holt

Exploration of Endocrine and Metabolic Diseases ›› 2024, Vol. 1 ›› Issue (4) : 167 -76.

PDF (7309KB)
Exploration of Endocrine and Metabolic Diseases ›› 2024, Vol. 1 ›› Issue (4) :167 -76. DOI: 10.37349/eemd.2024.00014
Original Article
research-article
Glycemic trends, app engagement and achievement of gestational diabetes guideline targets using a diabetes app and Bluetooth® connected blood glucose meters
Author information +
History +
PDF (7309KB)

Abstract

Aim: Current diabetes guidelines recommend people with gestational diabetes mellitus (PwGDM) use primarily blood glucose meters (BGM) for diabetes management. We evaluated glycemic trends and guideline-recommended glycemic targets achieved in PwGDM using a diabetes app with a family of Bluetooth® connected BGMs. Methods: Anonymized glucose and app analytics data from 26,382 PwGDM were sourced from a server. Data from their first 7-days using the app with connected BGMs was compared to 7-days prior to a 10-week timepoint. Results: Percent fasting readings in range (RIR, < 5.3 mmol/L) improved by +20.3 percentage points in the overall population. Improved glucose RIR (3.5 to 7.8 mmol/L) (+8.3 percentage points), mean blood glucose (BG, –0.59 mmol/L), and fasting RIR (+33.2 percentage points) were observed in those with baseline mean BG ≥ 6.1 mmol/L. Improvements in mean BG of –0.32 to –2.36 mmol/L, and RIR of +3.0 to +38.3 percentage points correlated with higher baseline mean BG ≥ 6.1 to ≥ 7.8 mmol/L. Only 58.5% of PwGDM with baseline mean BG ≥ 6.1 mmol/L had > 80% RIR at baseline, which improved to 79.5% at 10 weeks. PwGDM averaged 17 app sessions and 90 minutes per week on the app. Conclusions: PwGDM engaged with the diabetes app and connected BGM, facilitating attainment of glycemic targets, an especially important outcome for those with higher mean glucose at baseline.

Keywords

Gestational diabetes / real world evidence / diabetes mobile app / connected blood glucose meters

Cite this article

Download citation ▾
Mike Grady, Hilary Cameron, Elizabeth Holt. Glycemic trends, app engagement and achievement of gestational diabetes guideline targets using a diabetes app and Bluetooth® connected blood glucose meters. Exploration of Endocrine and Metabolic Diseases, 2024, 1 (4) : 167-76 DOI:10.37349/eemd.2024.00014

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Wang H, Li N, Chivese T, Werfalli M, Sun H, Yuen L, et al.; IDF Diabetes Atlas Committee Hyperglycaemia in Pregnancy Special Interest Group. IDF Diabetes Atlas: Estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group’s Criteria. Diabetes Res Clin Pract. 2022; 183: 109050.

[2]

Sweeting A, Wong J, Murphy HR, Ross GP. A Clinical Update on Gestational Diabetes Mellitus. Endocr Rev. 2022; 43: 763-93.

[3]

HAPO Study Cooperative Research Group; Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008; 358: 1991-2002.

[4]

American Diabetes Association Professional Practice Committee. 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes-2024. Diabetes Care. 2024; 47: S282-94.

[5]

Yamamoto JM, Murphy HR. Benefits of Real-Time Continuous Glucose Monitoring in Pregnancy. Diabetes Technol Ther. 2021; 23: S8-14.

[6]

Murphy HR, Howgate C, O’Keefe J, Myers J, Morgan M, Coleman MA, et al. Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study. Lancet Diabetes Endocrinol. 2021; 9: 153-64.

[7]

García-Moreno RM, Benítez-Valderrama P, Barquiel B, Pérez-de-Villar NG, Hillman N, Pablos DL, et al. Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials. Diabet Med. 2022; 39: e14703.

[8]

Wyckoff JA, Brown FM. Time in Range in Pregnancy: Is There a Role? Diabetes Spectr. 2021; 34: 119-32.

[9]

Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 2019; 42: 1593-603.

[10]

Setford S, Smith A, McColl D, Grady M, Koria K, Cameron H. Evaluation of the performance of the OneTouch Select® Plus blood glucose test system against ISO 15197:2013. Expert Rev Med Devices. 2015;12:771-81.

[11]

Bailey T, Chang A, Rosenblit PD, Jones L, Teft G, Setford S, et al. A comprehensive evaluation of the performance of the test strip technology for OneTouch Verio glucose meter systems. Diabetes Technol Ther. 2012; 14: 701-9.

[12]

Poulter SE, Meloncelli N, Mack M. Use of a smartphone-based, interactive blood glucose management system in women with gestational diabetes mellitus: A pilot study. Diabetes Res Clin Pract. 2022; 185: 109224.

[13]

Katz LB, Aparicio M, Cameron H, Ceppa F. Use of a Meter With Color-Range Indicators and a Mobile Diabetes Management App Improved Glycemic Control and Patient Satisfaction in an Underserved Hispanic Population: “Tu Salud”-A Randomized Controlled Partial Cross-Over Clinical Study. Diabetes Spectr. 2022; 35: 86-94.

[14]

Greenwood DA, Grady M. Healthcare Professional Perceptions of Blood Glucose Meter Features That Support Achievement of Self-Management Goals Recommended by Clinical Practice Guidelines. J Diabetes Sci Technol. 2021; 15: 1142-52.

[15]

Horgan R, Pierce-Williams R, Saccone G, Berghella V. Reminder systems to increase compliance with glucose logging in gestational diabetes: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2022; 4: 100586.

[16]

Pierce-Williams R, Sendek K, Firman B, Berghella V. Increased compliance with gestational diabetes mellitus glucose monitoring using a novel software. Am J Obstet Gynecol MFM. 2023; 5: 100890.

[17]

Chehab RF, Ferrara A, Greenberg MB, Ngo AL, Feng J, Zhu Y. Glycemic Control Trajectories and Risk of Perinatal Complications Among Individuals With Gestational Diabetes. JAMA Netw Open. 2022; 5: e2233955.

[18]

Wernimont SA, Sheng JS, Tymkowicz A, Fleener DK, Summers KM, Syrop CH, et al. Adherence to self-glucose monitoring recommendations and perinatal outcomes in pregnancies complicated by diabetes mellitus. Am J Obstet Gynecol MFM. 2019; 1: 100031.

[19]

Pigato F, Candido R, Zanette G, Zamagni G, Trojniak MP, Brunato B, et al. Gestational diabetes mellitus: Impact of adherence on patient management and maternal-neonatal complications. Prim Care Diabetes. 2023; 17: 486-92.

[20]

Scifres CM, Mead-Harvey C, Nadeau H, Reid S, Pierce S, Feghali M, et al. Intensive glycemic control in gestational diabetes mellitus: a randomized controlled clinical feasibility trial. Am J Obstet Gynecol MFM. 2019; 1: 100050.

[21]

Finneran MM, Kiefer MK, Ware CA, Buschur EO, Thung SF, Landon MB, et al. The use of longitudinal hemoglobin A1c values to predict adverse obstetric and neonatal outcomes in pregnancies complicated by pregestational diabetes. Am J Obstet Gynecol MFM. 2020; 2: 100069.

[22]

Cosson E, Baz B, Gary F, Pharisien I, Nguyen MT, Sandre-Banon D, et al. Poor Reliability and Poor Adherence to Self-Monitoring of Blood Glucose Are Common in Women With Gestational Diabetes Mellitus and May Be Associated With Poor Pregnancy Outcomes. Diabetes Care. 2017; 40: 1181-6.

[23]

Given JE, O’Kane MJ, Bunting BP, Coates VE. Comparing patient-generated blood glucose diary records with meter memory in diabetes: a systematic review. Diabet Med. 2013; 30: 901-13.

[24]

Ryan EA, Savu A, Yeung RO, Moore LE, Bowker SL, Kaul P. Elevated fasting vs post-load glucose levels and pregnancy outcomes in gestational diabetes: a population-based study. Diabet Med. 2020; 37: 114-22.

PDF (7309KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉